日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparative Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1-RAs) in Type 2 Diabetes and Chronic Weight Management: A Real-World Data Study

胰高血糖素样肽-1受体激动剂(GLP-1-RAs)在2型糖尿病和慢性体重管理中的安全性比较:一项真实世界数据研究

Hurwitz, Sarah Ruth; Lanes, Stephan; Quimbo, Tracey; Papazian, Anahit; White, Jeff; Fisher, Vicki; Cziraky, Mark J; Crowley, Matthew J; Willey, Vincent J

Everyday Discrimination and Vulnerability to HIV Transmission Among Sexual and Gender Minorities of Color in Raleigh-Durham, North Carolina

北卡罗来纳州罗利-达勒姆地区有色性少数群体和性别少数群体面临的日常歧视和艾滋病毒传播风险

Craven, Dalton M; Dennis, Ann M; Quimbo, Justin; Piang, Kham S K; Skaathun, Britt

Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models

抗HSP47 siRNA脂质纳米颗粒ND-L02-s0201可逆转临床前大鼠模型中的间质性肺纤维化

Liu, Yun; Liu, Jian; Quimbo, Alistair; Xia, Fengcheng; Yao, Jiping; Clamme, Jean-Pierre; Zabludoff, Sonya; Zhang, Jun; Ying, Wenbin

Health Plan Enrollment and Disenrollment of Individuals With and Without Established Chronic Disease in a U.S. Commercially Insured and Medicare Advantage Population

美国商业保险和联邦医疗保险优势计划人群中,患有和未患有慢性疾病的个人的健康计划参保和退保情况

Chung, Haechung; Deshpande, Gaurav; Zolotarjova, Julia; Quimbo, Ralph A; Kern, David M; Cochetti, Philip T; Willey, Vincent J

Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus

V-Go 与每日多次注射对 2 型糖尿病患者血糖控制、胰岛素用量和糖尿病药物费用的影响

Raval, Amit D; Nguyen, Matthew H; Zhou, Siting; Grabner, Michael; Barron, John; Quimbo, Ralph

Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population

商业保险人群中新确诊类风湿性关节炎患者的治疗模式

Kern, David M; Chang, Lawrence; Sonawane, Kalyani; Larmore, Cynthia J; Boytsov, Natalie N; Quimbo, Ralph A; Singer, Joseph; Hinton, John T; Wu, Sze-Jung; Araujo, Andre B

Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease

动脉粥样硬化性心血管疾病患者的临床特征、降脂药物使用模式、医疗资源利用情况及费用

Power, Thomas P; Ke, Xuehua; Zhao, Zhenxiang; Bonine, Nicole Gidaya; Cziraky, Mark J; Grabner, Michael; Barron, John J; Quimbo, Ralph; Vangerow, Burkhard; Toth, Peter P

A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data

对从一项新型癌症护理质量计划中采集的临床数据进行验证,该计划与行政索赔数据直接集成

Kern, David M; Barron, John J; Wu, Bingcao; Ganetsky, Alex; Willey, Vincent J; Quimbo, Ralph A; Fisch, Michael J; Singer, Joseph; Nguyen, Ann; Mamtani, Ronac

The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting

5-羟色胺受体拮抗剂对化疗依从性、治疗延迟以及恶心呕吐的影响

Palli, Swetha Rao; Grabner, Michael; Quimbo, Ralph A; Rugo, Hope S

The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy

INITIATOR 研究:美国 2 型糖尿病患者开始注射治疗后真实世界临床和经济结果的试点数据

Thayer, Sarah; Wei, Wenhui; Buysman, Erin; Brekke, Lee; Crown, William; Grabner, Michael; Raparla, Swetha; Quimbo, Ralph; Cziraky, Mark J; Hu, Wenli; Cuddihy, Robert